2032 related articles for article (PubMed ID: 28619367)
1. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
2. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
3. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
4. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
5. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.
Zhuo JL; Li XC
J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):23-33. PubMed ID: 17487823
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system revisited.
Fyhrquist F; Saijonmaa O
J Intern Med; 2008 Sep; 264(3):224-36. PubMed ID: 18793332
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system in the kidney: What is new?
Ferrão FM; Lara LS; Lowe J
World J Nephrol; 2014 Aug; 3(3):64-76. PubMed ID: 25332897
[TBL] [Abstract][Full Text] [Related]
9. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
10. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
11. Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.
Reyes S; Varagic J; Ahmad S; VonCannon J; Kon ND; Wang H; Groban L; Cheng CP; Dell'Italia LJ; Ferrario CM
Curr Hypertens Rep; 2017 Feb; 19(2):16. PubMed ID: 28233239
[TBL] [Abstract][Full Text] [Related]
12. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
Li XC; Zhuo JL
Curr Hypertens Rep; 2016 Aug; 18(8):63. PubMed ID: 27372447
[TBL] [Abstract][Full Text] [Related]
14. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
15. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
[TBL] [Abstract][Full Text] [Related]
16. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
17. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
19. Role of non-classical renin-angiotensin system axis in renal fibrosis.
Lv LL; Liu BC
Front Physiol; 2015; 6():117. PubMed ID: 25954204
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system and its receptors.
Stroth U; Unger T
J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S21-8; discussion S41-3. PubMed ID: 10028950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]